These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25726335)

  • 1. Marker of lipid peroxidation related to diabetic nephropathy in Indonesian type 2 diabetes mellitus patients.
    Sauriasari R; Andrajati R; Azizahwati ; Dharmeizar ; Saputri DA; Muris RU; Manfaatun A; Amanda OF; Setiawan H; Sakano N; Wang DH; Ogino K
    Diabetes Res Clin Pract; 2015 Apr; 108(1):193-200. PubMed ID: 25726335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Correlation Between Urinary 8-Iso-Prostaglandin F2α and Hydrogen Peroxide Toward Renal Function in T2DM Patients Consuming Sulfonylurea and Combination of Metformin-Sulfonylurea.
    Sauriasari R; Wulandari F; Nurifahmi R; Sekar AP; Susilo VY
    Curr Diabetes Rev; 2018; 14(2):189-195. PubMed ID: 27981897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.
    Rossing P; Rossing K; Gaede P; Pedersen O; Parving HH
    Diabetes Care; 2006 May; 29(5):1024-30. PubMed ID: 16644632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy.
    Akpınar K; Aslan D; Fenkçi SM
    J Bras Nefrol; 2021; 43(3):340-348. PubMed ID: 33599678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
    Chou ST; Tseng ST
    Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function decrement in type 2 diabetes mellitus patients in Cipto Mangunkusumo Hospital.
    Triyanti K; Suhardjono ; Soewondo P; Shatri H
    Acta Med Indones; 2008 Oct; 40(4):192-200. PubMed ID: 19530368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial.
    Fallahzadeh MK; Dormanesh B; Sagheb MM; Roozbeh J; Vessal G; Pakfetrat M; Daneshbod Y; Kamali-Sarvestani E; Lankarani KB
    Am J Kidney Dis; 2012 Dec; 60(6):896-903. PubMed ID: 22770926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
    Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration.
    Apakkan Aksun S; Ozmen B; Ozmen D; Parildar Z; Senol B; Habif S; Mutaf I; Turgan N; Bayindir O
    J Diabetes Complications; 2003; 17(6):343-8. PubMed ID: 14583179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals.
    Camargo EG; Soares AA; Detanico AB; Weinert LS; Veronese FV; Gomes EC; Silveiro SP
    Diabet Med; 2011 Jan; 28(1):90-5. PubMed ID: 21166850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2214-7. PubMed ID: 16569732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in advanced chronic renal failure.
    Teruel Briones JL; Gomis Couto A; Sabater J; Fernández Lucas M; Rodríguez Mendiola N; Villafruela JJ; Quereda C
    Nefrologia; 2011; 31(6):677-82. PubMed ID: 22130283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
    Fontseré N; Salinas I; Bonal J; Bayés B; Riba J; Torres F; Rios J; Sanmartí A; Romero R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2152-8. PubMed ID: 16702203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease.
    Vazzana N; Santilli F; Lattanzio S; Liani M; Giacci L; Del Rosso G; Salvati F; Boccatonda A; Ferroni P; Davì G
    Eur J Intern Med; 2016 Sep; 33():74-80. PubMed ID: 27389698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of urinary 8-iso-PGF2alpha using liquid chromatography-tandem mass spectrometry and association with elevated troponin levels.
    Saenger AK; Laha TJ; Edenfield MJ; Sadrzadeh SM
    Clin Biochem; 2007 Nov; 40(16-17):1297-304. PubMed ID: 17854792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.